+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030

  • ID: 4898044
  • Report
  • January 2020
  • Region: Global
  • 486 Pages
  • The Business Research Company

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AniCura
  • Biotex Plus Ltd
  • Dechra Holdings US
  • Jurox Pty Ltd
  • Putney Inc.
  • Vetoquinol S.A.
  • MORE

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030 from the author provides the strategists, marketers and senior management with the critical information they need to assess the global veterinary pharmaceuticals market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Gain a global perspective on the development of the market.

Description:
Where is the largest and fastest-growing market for the veterinary pharmaceuticals market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global veterinary pharmaceutical market report to 2030 from the author answers all these questions and many more.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives a brief introduction about segmentation by geography and segmentation by type.
  • Market Characteristics – The market characteristics section of the report defines and explains the veterinary pharmaceuticals market. This chapter includes different goods covered in the report and basic definitions.
  • Supply Chain – The supply chain section of the report defines and explains the key players in the veterinary pharmaceutical industry supply chain.
  • Product Analysis – The product analysis section of the report describes the leading products in the market along with key features and differentiators for those products.
  • Customer Information – This chapter covers recent customers’ trends/preferences in the global veterinary pharmaceutical market.
  • Trends And Strategies – This chapter describes the major trends shaping the global veterinary pharmaceuticals market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Regulatory Landscape – This section describes the current regulatory scenario, the regional disparities in regulations, global regulation harmonization initiatives, and recent updates on veterinary pharmaceutical regulations.
  • Impact Of Veterinary Services On The Veterinary Pharmaceuticals Market – This chapter describes the impact of veterinary services on the veterinary pharmaceuticals market, and comparison between the veterinary services, veterinary medical equipment and veterinary pharmaceuticals markets across major countries.
  • Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2023, 2025 and 2030) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
  • Market Segmentation – This section contains the market values (2015-2029, 2023, 2025 and 2030) and analysis for different segments and sub-segments in the market.
  • Regional And Country Analysis – This section contains the historic (2015-2019), forecast (2023, 2025 and 2030) market value and growth and market share comparison by region and countries.
  • Regional Market Size And Growth – This section contains the region’s market size (2019), historic and forecast (2015-2019, 2023, 2025 and 2030) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa).
  • Competitive Landscape – This section covers details on the competitive landscape of the global veterinary pharmaceuticals market, estimated market shares and company profiles of the leading players.
  • Key Mergers And Acquisitions – This chapter gives information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions that have shaped the market in recent years.
  • Market Background – This section describes the animal medicine market of which the veterinary pharmaceuticals market is a segment. This chapter includes the animal medicine market 2015-23 values, and regional analyses for the animal medicine market.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on the findings of the research. This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is a significant business to be gained by competitors in the next five years.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report

Markets Covered:

  • By Type Of Pharmaceutical: Veterinary Parasiticides; Veterinary Vaccines; Others - Veterinary Pharmaceuticals; Veterinary Antibiotics
  • By Animal Type: Livestock; Companion Animal
  • By Route of Administration: Oral; Others
  • By End-Use: Veterinary Hospitals; Pharmacies And Drug Stores; Veterinary Clinics
  • Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim International GmbH; Merck & Co., Inc.; Elanco Animal Health Inc.; Bayer AG
  • Countries: China, India, Japan, Australia, South Korea, Indonesia, USA, Brazil, UK, Germany, France, Russia
  • Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time-series: Five years historic and forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AniCura
  • Biotex Plus Ltd
  • Dechra Holdings US
  • Jurox Pty Ltd
  • Putney Inc.
  • Vetoquinol S.A.
  • MORE

1. Veterinary Pharmaceuticals Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1.1. Segmentation By Geography
6.1.2. By Type Of Pharmaceutical
6.1.3. Segmentation By Animal Type
6.1.4. Segmentation By Route of Administration
6.1.5. Segmentation By End Use Channel

7. Veterinary Pharmaceuticals Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Type Of Product
7.2.1. Veterinary Vaccines
7.2.2. Veterinary Antibiotics
7.2.3. Veterinary Parasiticides
7.2.4. Others - Veterinary Pharmaceuticals
7.3. Market Segmentation By End User
7.3.1. Veterinary Hospitals
7.3.2. Veterinary Clinics
7.3.3. Pharmacies And Drug Stores
7.4. Market Segmentation By Route Of Administration
7.4.1. Oral
7.4.2. Others
7.5. Market Segmentation By Type Of Animal
7.5.1. Livestock
7.5.2. Companion Animals
7.6. Market Segmentation By Vaccines
7.6.1. Inactivated Vaccines
7.6.2. Attenuated Vaccines
7.6.3. Recombinant Vaccines
7.6.4. Others
7.7. Market Segmentation By Antibiotics
7.7.1. Tetracyclines
7.7.2. Penicillins
7.7.3. Sulphonamides
7.7.4. Macrolides
7.7.5. Aminoglycosides
7.7.6. Others

8. Veterinary Pharmaceuticals Market, Supply Chain Analysis
8.1.1. Raw Material Suppliers
8.1.2. Contract Research Organization (CRO)
8.1.3. Veterinary Pharmaceutical Manufacturer
8.1.4. Contract Manufacturing Organization (CMO)
8.1.5. Wholesalers/Distributors
8.1.6. Retailers (Pharmacies And Veterinary Shops) And Veterinary Clinics
8.1.7. End-Users

9. Veterinary Pharmaceuticals Market, Product Analysis – Product Examples

10. Veterinary Pharmaceuticals Market Customer Information
10.1.1. Opioids Shortages Compel Veterinarians To Use Less Effective Drugs As Therapeutic Choices
10.1.2. U.S. Veterinarians Are Reluctant To Discuss The Therapeutic Use Of Marijuana In Dogs
10.1.3. Pet Ownership In The USA Has Tripled Over The Past Few Years
10.1.4. Cat And Dog Medications Are Still Sold Mainly In Veterinary Clinics
10.1.5. Pet Insurance Penetration In The USA Is Very Low
10.1.6. Pet Obesity Remains A Big Issue
10.1.7. The More Pet Owners Learn About Scientific Research On The Benefits Of The Human-Animal Bond, The More Likely They Are To Take Actions To Improve Pet Health.
10.1.8. Dog And Cat Owners Alike Are Concerned About The Cost Of Medical Treatments For Their Pets

11. Veterinary Pharmaceuticals Market Trends And Strategies
11.1. Strategic Collaborations And Partnerships To Drive Innovations
11.2. Development Of Chewable Tablets
11.3. Production Of Generic Drugs For Animal Care
11.4. Application Of Nanotechnology In Veterinary Medicines To Tackle Antibiotic Resistance
11.5. Oral Drug Solutions For The Treatment Of Feline Hypertension
11.6. Use of Subunit And Virus-Like Particle (VLP)-Based Vaccines
11.7. Use Of Immunotherapy

12. Global Veterinary Pharmaceuticals Market Regulatory Landscape
12.1. Need For Separate Regulation For The Veterinary Pharmaceuticals Industry
12.2. Current Regulatory Scenario
12.2.1. USA
12.2.2. Europe
12.2.3. India
12.2.4. Brazil
12.2.5. Australia and New Zealand
12.2.6. Africa
12.3. Regional Disparities In Regulations
12.3.1. Lack Of Regulatory Guidance
12.3.2. Variations In Veterinary Pharmaceuticals Development Processes
12.3.3. Variations In Safety Considerations For Veterinary Pharmaceuticals
12.3.4. Differences In Registration Procedures
12.4. Global-Regulation Harmonization Initiatives
12.5. Recent Updates On Veterinary Pharmaceutical Regulations

13. Impact Of Veterinary Services On The Veterinary Pharmaceuticals Market
13.1.1. USA
13.1.2. Japan
13.1.3. China
13.1.4. UK
13.1.5. Germany

14. Global Veterinary Pharmaceuticals Market Size And Growth
14.1. Historic And Forecast Market Growth, Value ($ Million)
14.1.1. Drivers Of The Market 2015-2019
14.1.2. Emerging Markets Growth
14.1.3. Increased Pet Spending
14.1.4. Increased Disease Prevalence
14.1.5. Restraints On The Market 2015-2019
14.1.6. Shortages Of Veterinarians
14.1.7. Drivers Of The Market 2019-2023
14.1.8. Economic Growth
14.1.9. Increasing Penetration Of Pet Insurance
14.1.10. Restraints On The Market 2019-2023

15. Global Veterinary Pharmaceuticals Market Segmentation
15.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.2. Global Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.3. Global Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.4. Global Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

16. Global Veterinary Pharmaceuticals Market Sub-Segmentation
16.1. Global Veterinary Vaccines Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
16.2. Global Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

17. Veterinary Pharmaceuticals Market, Regional And Country Analysis
17.1. Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.2. Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

18. Asia-Pacific Veterinary Pharmaceuticals Market
18.1. Asia-Pacific Veterinary Pharmaceuticals Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Background Information
18.1.4. Government Initiatives
18.1.5. Regulatory Bodies
18.1.6. Regulations
18.1.7. Corporate Tax Structure
18.1.8. Associations
18.1.9. Tax Levied
18.1.10. Investments
18.1.11. Major Companies
18.2. Asia-Pacific Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
18.3. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.4. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.5. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.6. Asia-Pacific Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.7. Asia-Pacific Veterinary Pharmaceuticals Market: Country Analysis
18.8. China Veterinary Pharmaceuticals Market
18.9. China Veterinary Pharmaceuticals Market Overview
18.9.1. Country Information
18.9.2. Market Information
18.9.3. Background Information
18.9.4. Regulatory Bodies
18.9.5. Regulations
18.9.6. Corporate Tax Structure
18.9.7. Associations
18.9.8. Tax Levied
18.9.9. Investments
18.9.10. Major Companies
18.10. China Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
18.11. China Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.12. China Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.13. China Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.14. China Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.15. India Veterinary Pharmaceuticals Market
18.16. India Veterinary Pharmaceuticals Market Overview
18.16.1. Country Information
18.16.2. Market Information
18.16.3. Background Information
18.16.4. Government Initiatives
18.16.5. Regulatory Bodies
18.16.6. Regulations
18.16.7. Corporate Tax Structure
18.16.8. Associations
18.16.9. Tax Levied
18.16.10. Investments
18.16.11. Major Companies
18.17. India Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
18.18. India Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.19. India Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.20. India Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.21. India Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.22. Japan Veterinary Pharmaceuticals Market
18.23. Japan Veterinary Pharmaceuticals Market Overview
18.23.1. Country Information
18.23.2. Market Information
18.23.3. Background Information
18.23.4. Government Initiatives
18.23.5. Regulatory Bodies
18.23.6. Regulations
18.23.7. Corporate Tax Structure
18.23.8. Associations
18.23.9. Tax Levied
18.23.10. Investments
18.23.11. Major Companies
18.24. Japan Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
18.25. Japan Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.26. Japan Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.27. Japan Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.28. Japan Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.29. Australia Veterinary Pharmaceuticals Market
18.30. Australia Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
18.31. Australia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.32. Australia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.33. Australia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.34. Australia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.35. Indonesia Veterinary Pharmaceuticals Market
18.36. Indonesia Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
18.37. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.38. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.39. Indonesia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.40. Indonesia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.41. South Korea Veterinary Pharmaceuticals Market
18.42. South Korea Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
18.43. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.44. South Korea Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.45. South Korea Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.46. South Korea Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Western Europe Veterinary Pharmaceuticals Market
19.1. Western Europe Veterinary Pharmaceuticals Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Background Information
19.1.4. Government Initiatives
19.1.5. Regulatory Bodies
19.1.6. Regulations
19.1.7. Corporate Tax Structure
19.1.8. Associations
19.1.9. Investments
19.1.10. Major Companies
19.2. Western Europe Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
19.3. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.4. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.5. Western Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.6. Western Europe Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.7. Western Europe Veterinary Pharmaceuticals Market: Country Analysis
19.8. UK Veterinary Pharmaceuticals Market
19.9. UK Veterinary Pharmaceuticals Market Overview
19.9.1. Country Information
19.9.2. Market Information
19.9.3. Background Information
19.9.4. Government Initiatives
19.9.5. Regulatory Bodies
19.9.6. Regulations
19.9.7. Corporate Tax Structure
19.9.8. Associations
19.9.9. Investments
19.9.10. Major Companies
19.10. UK Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
19.11. UK Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.12. UK Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.13. UK Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.14. UK Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.15. Germany Veterinary Pharmaceuticals Market
19.16. Germany Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
19.17. Germany Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.18. Germany Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.19. Germany Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.20. Germany Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.21. France Veterinary Pharmaceuticals Market
19.22. France Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
19.23. France Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.24. France Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.25. France Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.26. France Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

20. Eastern Europe Veterinary Pharmaceuticals Market
20.1. Eastern Europe Veterinary Pharmaceuticals Market Overview
20.1.1. Region Information
20.1.2. Market Information
20.1.3. Background Information
20.1.4. Regulatory Bodies
20.1.5. Regulations
20.1.6. Corporate Tax Structure
20.1.7. Associations
20.1.8. Tax Levied
20.1.9. Investment
20.1.10. Major Companies
20.2. Eastern Europe Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
20.3. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.4. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.5. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.6. Eastern Europe Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.7. Eastern Europe Veterinary Pharmaceuticals Market: Country Analysis
20.8. Russia Veterinary Pharmaceuticals Market
20.9. Russia Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
20.10. Russia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.11. Russia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.12. Russia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.13. Russia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

21. North America Veterinary Pharmaceuticals Market
21.1. North America Veterinary Pharmaceuticals Market Overview
21.1.1. Region Information
21.1.2. Market Information
21.1.3. Background Information
21.1.4. Government Initiatives
21.1.5. Regulatory Bodies
21.1.6. Regulations
21.1.7. Corporate Tax Structure
21.1.8. Associations
21.1.9. Tax Levied
21.1.10. Investments
21.1.11. Major Companies
21.2. North America Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
21.3. North America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.4. North America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.5. North America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.6. North America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.7. North America Veterinary Pharmaceuticals Market: Country Analysis
21.8. USA Veterinary Pharmaceuticals Market
21.9. USA Veterinary Pharmaceuticals Market Overview
21.9.1. Region Information
21.9.2. Market Information
21.9.3. Background Information
21.9.4. Government Initiatives
21.9.5. Regulatory Bodies
21.9.6. Regulations
21.9.7. Corporate Tax Structure
21.9.8. Associations
21.9.9. Tax Levied
21.9.10. Investments
21.9.11. Major Companies
21.10. USA Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
21.11. USA Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.12. USA Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.13. USA Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.14. USA Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

22. South America Veterinary Pharmaceuticals Market
22.1. South America Veterinary Pharmaceuticals Market Overview
22.1.1. Region Information
22.1.2. Market Information
22.1.3. Background Information
22.1.4. Regulatory Bodies
22.1.5. Regulations
22.1.6. Corporate Tax Structure
22.1.7. Associations
22.1.8. Tax Levied
22.1.9. Investments
22.1.10. Major Companies
22.2. South America Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
22.3. South America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.4. South America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.5. South America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.6. South America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.7. South America Veterinary Pharmaceuticals Market: Country Analysis
22.8. Brazil Veterinary Pharmaceuticals Market
22.9. Brazil Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
22.10. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.11. Brazil Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.12. Brazil Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.13. Brazil Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

23. Middle East Veterinary Pharmaceuticals Market
23.1. Middle East Veterinary Pharmaceuticals Market Overview
23.1.1. Region Overview
23.1.2. Market Information
23.1.3. Background Information
23.1.4. Regulatory Bodies
23.1.5. Regulations
23.1.6. Corporate Tax Structure
23.1.7. Associations
23.1.8. Major Companies
23.2. Middle East Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
23.3. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
23.4. Middle East Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
23.5. Middle East Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
23.6. Middle East Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

24. Africa Veterinary Pharmaceuticals Market
24.1. Africa Veterinary Pharmaceuticals Market Overview
24.1.1. Region Information
24.1.2. Market Information
24.1.3. Background Information
24.1.4. Regulatory Bodies
24.1.5. Regulations
24.1.6. Corporate Tax Structure
24.1.7. Associations
24.1.8. Investments
24.1.9. Major Companies
24.2. Africa Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
24.3. Africa Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
24.4. Africa Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
24.5. Africa Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
24.6. Africa Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

25. Global Veterinary Pharmaceuticals Market Competitive Landscape
25.1. Company Profiles
25.2. Zoetis Inc.
25.2.1. Company Overview
25.2.2. Products And Services
25.2.3. Business Strategy
25.2.4. Financial Overview
25.3. Boehringer Ingelheim International GmbH
25.3.1. Company Overview
25.3.2. Products And Services
25.3.3. Business Strategy
25.3.4. Financial Overview
25.4. Merck & Co., Inc.
25.4.1. Company Overview
25.4.2. Products And Services
25.4.3. Business Strategy
25.4.4. Financial Overview
25.5. Elanco Animal Health Inc.
25.5.1. Company Overview
25.5.2. Products And Services
25.5.3. Business Strategy
25.5.4. Financial Overview
25.6. Bayer AG
25.6.1. Company Overview
25.6.2. Products And Services
25.6.3. Business Strategy
25.6.4. Financial overview

26. Key Mergers And Acquisitions In The Veterinary Pharmaceuticals Market
26.1. Elanco Animal Health Acquired Bayer’s AG
26.2. Merck Animal Health Acquired Antelliq Corporation
26.3. Henry Schein Animal Health Merges With Vets First Choice
26.4. Mars Petcare Acquired AniCura
26.5. PHARMAQ Collaborated With Vinh Hoan
26.6. Animal Health Division Of Merck & Co. Collaborated With Vinovo
26.7. Wageningen Bioveterinary Research Collaborated With Ceva
26.8. Animalcare Group Acquired Ecuphar
26.9. Merck Animal Health Acquired Vallee S.A.
26.10. Elanco Animal Health Acquired Boehringer Ingelheim Vetmedica’s Vaccine Portfolio
26.11. Ceva Acquired Portfolio Of Merial Swine And Cattle Vaccines
26.12. Dechra Holdings US (A U.S Subsidiary of Dechra Pharmaceuticals PLC) Acquired Putney Inc.
26.13. Zydus Cadila Acquired Zoetis
26.14. Eli Lilly And Company Acquired Novartis Animal Health

27. Market Background: Animal Medicine
27.1. Animal Medicine Market Characteristics
27.1.1. Market Definition
27.1.2. Segmentation Type Of Medicine
27.2. Global Animal Medicine Market, Segmentation By Industry, 2015 - 2023, Value ($ Million)
27.3. Global Animal Medicine Market, 2019, By Region, Value ($ Million)
27.4. Global Animal Medicine Market, 2015 - 2023, Historic And Forecast, By Region

28. Global Veterinary Pharmaceuticals Market Opportunities And Strategies
28.1. Global Veterinary Pharmaceuticals Market In 2023 – Countries Offering Most New Opportunities
28.2. Global Veterinary Pharmaceuticals Market In 2023 – Segments Offering Most New Opportunities
28.3. Global Veterinary Pharmaceuticals Market In 2023 – Growth Strategies
28.3.1. Market Trend Based Strategies
28.3.2. Competitor Strategies

29. Veterinary Pharmaceuticals Market, Conclusions And Recommendations
29.1. Conclusions
29.2. Recommendations
29.2.1. Product
29.2.2. Place
29.2.3. Price
29.2.4. Promotion
29.2.5. People

30. Appendix
30.1. Market Data Sources
30.2. Research Methodology
30.3. Currencies
30.4. Research Inquiries
30.6. Copyright and Disclaimer

Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • AniCura
  • Biotex Plus Ltd
  • Dechra Holdings US
  • Jurox Pty Ltd
  • Putney Inc.
  • Vetoquinol S.A.
  • MORE

The veterinary pharmaceuticals market is highly regulated and complex, the specialized nature of the market has allowed for it to become quite concentrated amongst the major players. As it is driven forward with the growing popularity of pets in both developed and emerging economies, there will be space for innovations and investment into new treatments and therapies.

This global veterinary pharmaceuticals report describes and analyses the market, considering performance by county and segmentation. The report also covers qualitative analysis, assessing market conditions from an economic and trend perspective. It covers two five-year periods, 2015 to 2019, termed the historic period, and 2019 through 2023, the forecast period.

The veterinary pharmaceuticals market is complex by its very nature, with vast cultural and regulatory differences by country. It is however also a potentially very lucrative market, with many companies within it posting healthy profits. The author values the veterinary pharmaceuticals market at $33,762.4 million in 2019, having grown at a compound annual growth rate (CAGR) of 11.9% from $21,565.0 million in 2015. This steady growth is forecast to continue with a CAGR of 12.7% forecast for the next five years taking the market to a value of $54,471.5 million in 2023.

The US market dominates the veterinary pharmaceuticals market, however developing countries are presenting the fastest forecast growth

The majority of the veterinary pharmaceuticals market can be found in the US, with 43% of the market by value housed there.

Historically (2015-2019, CAGR), market growth in the US was 11.13%, which is not surprisingly similar to the global rate. However, moving forward, this growth is expected to slow somewhat with the forecast CAGR to 2023 at 10.86%. The higher global growth is being influenced by much faster growth in developing nations, where the veterinary pharmaceuticals market is quickly developing. In China for instance, the forecast CAGR to 2023 is 24.65%, and the same in Japan is 9.32%. These growth rates are highlighting strong and rapidly moving opportunities in these countries, and an opening for players in the market to establish themselves and their business at a crucial point as the market seeks to establish itself.

This does not however mean the US market is without opportunities for success. The US market is the largest in the world and by a huge majority. The size of the market is somewhat owing to the size of the economy, however there is also a strong culture of pet ownership in the US, and a high livestock population. With a long-established pet-community comes good quality veterinary care which will offer pet owners access to the veterinary pharmaceuticals required for the wellbeing of their animals. Likewise, with well-developed livestock practices comes many opportunities for the market to maintain a strong, healthy and profitable livestock.

Future targeting opportunities, for instance those in Parasiticides, can be identified with detailed segmentation

This report extensively segments the veterinary pharmaceuticals market in order to offer a detailed view of the market, as well as effectively highlighting current and future business opportunities. The pie charts below introduce the segmentations offered, as well as their share of the market.

The veterinary pharmaceuticals market is segmented by type of pharmaceutical into veterinary parasiticides, veterinary vaccines, veterinary antibiotics and others – veterinary pharmaceuticals. The veterinary parasiticides market was the largest segment of veterinary pharmaceuticals market, accounting for $9,912.8 million or 29.4% of the total market in 2019. The veterinary vaccines segment is expected to be the fastest-growing segment going forward at a CAGR of 13.7%.

The veterinary pharmaceuticals market is segmented by animal type into livestock and companion animal. The livestock was the largest segment of the veterinary pharmaceuticals market by animal type, accounting for $18,292.2 million or 54.2% of the total market in 2019. The companion animal segment is expected to be the fastest-growing segment going forward at a CAGR of 16.3%.

The veterinary pharmaceuticals market is segmented by route of administration into oral and others. The oral was the largest segment of the veterinary pharmaceuticals market by route of administration, accounting for $18,671.9 million or 55.3% of the total market in 2019.

The veterinary pharmaceuticals market is segmented by end use channel into veterinary hospitals, pharmacies and drug stores and veterinary clinics. The veterinary hospitals was the largest segment of the veterinary pharmaceuticals market by end use channel, accounting for $22,512.8 million or 66.7% of the total market in 2019. The veterinary clinics channel is expected to be the fastest-growing segment going forward at a CAGR of 15.2%.

Being technical and highly regulated, the veterinary pharmaceuticals market has high barriers to entry, allowing opportunities for those already operating in the market to grow their share

The veterinary pharmaceuticals market is concentrated with the top ten competitors in the market making up 68.5% of the total market in 2018. This means that the market is dominated by a few large players. This landscape is very likely to continue in the market owing to the major barriers to entry in such a market. Across all economies, the capital and expertise required to take a veterinary pharmaceuticals concept from development to market is vast, with many regulatory hurdles along the way.

Zoetis Inc. was the largest competitor with 16.6% of the market, followed by Boehringer Ingelheim International GmbH with 14.9%, Merck & Co., Inc. with 14.0%, Elanco Animal Health Inc. with 6.3%, Bayer AG with 5.6%, Ceva Santé Animale with 4.1%, Virbac Group with 3.1%, Phibro Animal Health Corporation with 1.4%, Vetoquinol S.A. with 1.1% and Kyoritsu Seiyaku Corporation with 1.1%.

Emerging economies and the overall rise in the popularity of the pet industry is driving the veterinary pharmaceuticals market

There are a number of factors driving the veterinary pharmaceuticals market forward including global economic developments and drivers linked with pet ownership. Growth in the emerging markets has been a key driver of historic growth as pet culture from the West spreads and results in rapidly growing markets for all related industries. Similarly, the demand for livestock grows along with an emerging country’s rapidly growing demands.

The growth of the pet industry, spanning increased pet ownership and the notion of a pet being an additional family member also drives this market. More people are forming strong emotional attachments to their pets, with the result being a willingness to spend on care that maintains or improves their health, including of course veterinary pharmaceuticals. Linked closely with this is the rising prevalence of pet insurance which will drive demand for veterinary pharmaceuticals as vets can offer them under the cover of the insurance plan. There is also evidence of rising prevalence of some animal diseases which will again drive demand for the appropriate pharmaceuticals.

The veterinary pharmaceuticals market is likely to be retrained somewhat by existing barriers to entry and a shortage of qualified veterinarians

Veterinary pharmaceuticals is a technical and complex market, meaning that there are key inhibitors to growth, as well as challenges to overcome. As well as strong barriers to entry for the market, including competition from large global players and a regulatory minefield, there is also a shortage of veterinarians. Lack of availability of trained veterinarians means fewer potential customers the pharmaceuticals have access to the trained person who could recommend the appropriate treatment.

Note: Product cover images may vary from those shown
  • Agrovet Market Animal Health
  • AniCura
  • Animalcare Group
  • Antelliq Corporation
  • BASF India Ltd.
  • Bayer AG
  • Bayer Animal Health Cadila Pharmaceuticals Ltd.
  • Belfarmacom
  • Bimeda
  • Biotex Plus Ltd
  • Boehringer Ingelheim
  • Brouwer
  • Cadila Pharmaceuticals Ltd
  • Cargill India Pvt. Ltd
  • Century Pharmaceuticals Limited
  • Ceva
  • Chemo Argentina
  • China Animal Healthcare Ltd.
  • DBK Pharma S.A.E
  • Dechra Holdings US
  • DS Pharma Animal Health Co. Ltd
  • Ecuphar
  • Elanco Animal Health
  • Eli Lilly And Company
  • Fujita Pharmaceutical
  • Henry Schein Animal Health
  • IDT Biologika
  • Interfeed
  • Intervet Australia Pty Ltd
  • Jurox Pty Ltd
  • Kyoritsu Seiyaku Corporation
  • Lemavet
  • Mars Petcare
  • Merck & Co Inc.
  • Merck/MSD Animal Health
  • Merial Swine And Cattle Vaccines
  • Nimrod Veterinary Products Ltd
  • Novartis Animal Health
  • PHARMAQ
  • Phibro Animal Health Corporation
  • Putney Inc.
  • Saudi Pharmaceutical Industries (SPI)
  • Sauvet
  • Syntec
  • UCBVET
  • Vallee S.A.
  • Vetanco
  • Vetmedica
  • Vetoquinol S.A.
  • Vets First Choice
  • Vinh Hoan
  • Vinovo
  • Virbac Group
  • Wageningen Bioveterinary Research
  • ZENOAQ
  • Zoetis
  • Zydus Cadila
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll